These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6279372)

  • 21. [Corticotropic function of the pituitary gland in Cushing's syndrome treated with chloditane].
    Slavnov VN; Luchitskiĭ EV; Komissarenko IV; Cheban AK
    Ter Arkh; 1978; 50(11):72-5. PubMed ID: 214890
    [No Abstract]   [Full Text] [Related]  

  • 22. Pituitary pathology in Cushing's disease. Histology and morphometry of pituitary tissues removed through microsurgery.
    Olivier L; Vila-Porcile E
    Pathol Res Pract; 1988 Sep; 183(5):587-91. PubMed ID: 3237548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary adenomas in Cushing's disease. A histologic, ultrastructural, and immunocytochemical study.
    Robert F; Pelletier G; Hardy J
    Arch Pathol Lab Med; 1978 Sep; 102(9):448-55. PubMed ID: 80206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of intermediate lobe differentiation in the human pituitary gland.
    McNicol AM
    J Pathol; 1986 Nov; 150(3):169-73. PubMed ID: 3543273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ultrastructure of the pituitary gland under chronic stimulation of the ACTH-cells in human pathology and animal experiments.
    Caselitz J; Saeger W
    Endokrinologie; 1979; 74(2):163-76. PubMed ID: 231515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility.
    Oldfield EH; Vance ML; Louis RG; Pledger CL; Jane JA; Lopes MB
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remission of pituitary-dependent Cushing's disease after removal of nonneoplastyic pituitary gland.
    Taylor HC; Velasco ME; Brodkey JS
    Arch Intern Med; 1980 Oct; 140(10):1366-8. PubMed ID: 6252859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical treatment of Cushing's disease.
    Chandler WF; Schteingart DE; Lloyd RV; McKeever PE; Ibarra-Perez G
    J Neurosurg; 1987 Feb; 66(2):204-12. PubMed ID: 3806203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Electron microscope study of "basophil" secretion particles in tumoral hypophyseal cells in Cushing's disease].
    Olivier L; Vila-Porcile E; Peillon F; Racadot J
    C R Seances Soc Biol Fil; 1972; 166(12):1591-5. PubMed ID: 4665258
    [No Abstract]   [Full Text] [Related]  

  • 30. A study of corticotroph adenomas in Cushing's disease: no evidence of intermediate lobe origin.
    McNicol AM; Teasdale GM; Beastall GH
    Clin Endocrinol (Oxf); 1986 Jun; 24(6):715-22. PubMed ID: 3024871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purves symposium: 2. Pituitary morphology in relationship to function. General principles.
    Purves HD
    N Z Med J; 1974 Dec; 80(530):548-51. PubMed ID: 4141489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinico-pathological study of two patients with Cushing's disease.
    Croxson MS; Synek BJ
    N Z Med J; 1980 Nov; 92(671):349-51. PubMed ID: 6256694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Case report: bilateral Cushing's syndrome].
    Cheikhrouhou H; Khiari K; Chérif L; Ben Abdallah N; Ben Maïz H
    Tunis Med; 2003 Apr; 81(4):277-82. PubMed ID: 12848013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.
    Hsu DW; Hooi SC; Hedley-Whyte ET; Strauss RM; Kaplan LM
    Am J Pathol; 1991 Apr; 138(4):897-909. PubMed ID: 1707237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cushing's disease with corticotropic microadenoma and empty sella turcica].
    Leutenegger M; Gross A; Hublot C
    Nouv Presse Med; 1982 Feb; 11(6):454-5. PubMed ID: 6278400
    [No Abstract]   [Full Text] [Related]  

  • 36. Extrapituitary parasellar microadenoma in Cushing's disease.
    Pluta RM; Nieman L; Doppman JL; Watson JC; Tresser N; Katz DA; Oldfield EH
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2912-23. PubMed ID: 10443699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolactin measurement during inferior petrosal sinus sampling improves the localization of pituitary adenomas in Cushing's disease.
    Mulligan GB; Faiman C; Gupta M; Kennedy L; Hatipoglu B; Hui F; Weil RJ; Hamrahian AH
    Clin Endocrinol (Oxf); 2012 Aug; 77(2):268-74. PubMed ID: 22243215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of inferior petrosal sinus venous endocrine markers in Cushing's disease.
    Zovickian J; Oldfield EH; Doppman JL; Cutler GB; Loriaux DL
    J Neurosurg; 1988 Feb; 68(2):205-10. PubMed ID: 2828570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Autopsy case of Cushing's syndrome caused by malignant thymoma].
    Miyoshi T; Sumiyoshi A
    Nihon Naibunpi Gakkai Zasshi; 1968 Jan; 43(10):977-82. PubMed ID: 4298017
    [No Abstract]   [Full Text] [Related]  

  • 40. A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism.
    Tahara S; Kurotani R; Ishii Y; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 2002 Oct; 15(10):1102-5. PubMed ID: 12379758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.